FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056309095> ?p ?o ?g. }

• W2056309095 endingPage "594.e1" @default.
• W2056309095 startingPage "589" @default.
• W2056309095 abstract "Purpose To determine whether a three-year fluocinolone acetonide sustained drug delivery system can be implanted safely at the same time that phacoemulsification and intraocular lens (IOL) implantation are performed for a visually significant cataract in eyes with uveitis. Design Retrospective, single-center case series. Methods All consecutive patients treated from April 1998 through September 2006 at an academic clinical practice with intermediate uveitis, posterior uveitis, or panuveitis requiring immunosuppressive therapy, periocular corticosteroid injections, or both. Phacoemulsification, IOL implantation, and fluocinolone acetonide implant insertion were performed during a single surgical session. The main outcome measures were preoperative and postoperative ocular inflammation, visual acuity (VA), intraoperative complications, anti-inflammatory medication use, IOP, and postoperative adverse events. Results Twenty-four eyes of 21 patients were studied. Mean follow-up duration was 27 months (range, six to 60 months). No patients had intraoperative complications. The mean Snellen VA at baseline was 20/316, which improved significantly to 20/75 at 12 months. The average number of recurrences in the 12 months before implantation was 2.2 episodes per eye. Only one eye experienced a recurrence at seven months after implantation. Topical corticosteroids, posterior sub-Tenon capsule injections, and systemic anti-inflammatory medications were reduced significantly at 12 months. Average IOP was unchanged after surgery compared with preoperative IOP; 15% underwent glaucoma filtering surgery. Conclusions A fluocinolone acetonide implant insertion can be combined safely with phacoemulsification plus IOL implantation during the same surgical session in eyes with uveitis. VA generally was improved, uveitis recurrences decreased, and the need for immunosuppression decreased. The most common side effect was increased IOP. To determine whether a three-year fluocinolone acetonide sustained drug delivery system can be implanted safely at the same time that phacoemulsification and intraocular lens (IOL) implantation are performed for a visually significant cataract in eyes with uveitis. Retrospective, single-center case series. All consecutive patients treated from April 1998 through September 2006 at an academic clinical practice with intermediate uveitis, posterior uveitis, or panuveitis requiring immunosuppressive therapy, periocular corticosteroid injections, or both. Phacoemulsification, IOL implantation, and fluocinolone acetonide implant insertion were performed during a single surgical session. The main outcome measures were preoperative and postoperative ocular inflammation, visual acuity (VA), intraoperative complications, anti-inflammatory medication use, IOP, and postoperative adverse events. Twenty-four eyes of 21 patients were studied. Mean follow-up duration was 27 months (range, six to 60 months). No patients had intraoperative complications. The mean Snellen VA at baseline was 20/316, which improved significantly to 20/75 at 12 months. The average number of recurrences in the 12 months before implantation was 2.2 episodes per eye. Only one eye experienced a recurrence at seven months after implantation. Topical corticosteroids, posterior sub-Tenon capsule injections, and systemic anti-inflammatory medications were reduced significantly at 12 months. Average IOP was unchanged after surgery compared with preoperative IOP; 15% underwent glaucoma filtering surgery. A fluocinolone acetonide implant insertion can be combined safely with phacoemulsification plus IOL implantation during the same surgical session in eyes with uveitis. VA generally was improved, uveitis recurrences decreased, and the need for immunosuppression decreased. The most common side effect was increased IOP." @default.
• W2056309095 created "2016-06-24" @default.
• W2056309095 creator A5001741893 @default.
• W2056309095 creator A5051024053 @default.
• W2056309095 creator A5090864408 @default.
• W2056309095 date "2008-10-01" @default.
• W2056309095 modified "2023-09-28" @default.
• W2056309095 title "Combined Fluocinolone Acetonide Intraocular Delivery System Insertion, Phacoemulsification, and Intraocular Lens Implantation for Severe Uveitis" @default.
• W2056309095 cites W1606072215 @default.
• W2056309095 cites W1985700625 @default.
• W2056309095 cites W1989576823 @default.
• W2056309095 cites W2008309504 @default.
• W2056309095 cites W2013685772 @default.
• W2056309095 cites W2023361029 @default.
• W2056309095 cites W2036807452 @default.
• W2056309095 cites W2060359798 @default.
• W2056309095 cites W2062054115 @default.
• W2056309095 cites W2067824799 @default.
• W2056309095 cites W2100306492 @default.
• W2056309095 cites W2108602187 @default.
• W2056309095 cites W2151486474 @default.
• W2056309095 doi "https://doi.org/10.1016/j.ajo.2008.05.035" @default.
• W2056309095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18639220" @default.
• W2056309095 hasPublicationYear "2008" @default.
• W2056309095 type Work @default.
• W2056309095 sameAs 2056309095 @default.
• W2056309095 citedByCount "34" @default.
• W2056309095 countsByYear W20563090952012 @default.
• W2056309095 countsByYear W20563090952013 @default.
• W2056309095 countsByYear W20563090952014 @default.
• W2056309095 countsByYear W20563090952015 @default.
• W2056309095 countsByYear W20563090952016 @default.
• W2056309095 countsByYear W20563090952018 @default.
• W2056309095 countsByYear W20563090952019 @default.
• W2056309095 countsByYear W20563090952022 @default.
• W2056309095 countsByYear W20563090952023 @default.
• W2056309095 crossrefType "journal-article" @default.
• W2056309095 hasAuthorship W2056309095A5001741893 @default.
• W2056309095 hasAuthorship W2056309095A5051024053 @default.
• W2056309095 hasAuthorship W2056309095A5090864408 @default.
• W2056309095 hasConcept C118487528 @default.
• W2056309095 hasConcept C141071460 @default.
• W2056309095 hasConcept C2776194053 @default.
• W2056309095 hasConcept C2776804153 @default.
• W2056309095 hasConcept C2777463590 @default.
• W2056309095 hasConcept C2778257484 @default.
• W2056309095 hasConcept C2778527774 @default.
• W2056309095 hasConcept C2779567214 @default.
• W2056309095 hasConcept C2781104129 @default.
• W2056309095 hasConcept C2781411149 @default.
• W2056309095 hasConcept C71924100 @default.
• W2056309095 hasConceptScore W2056309095C118487528 @default.
• W2056309095 hasConceptScore W2056309095C141071460 @default.
• W2056309095 hasConceptScore W2056309095C2776194053 @default.
• W2056309095 hasConceptScore W2056309095C2776804153 @default.
• W2056309095 hasConceptScore W2056309095C2777463590 @default.
• W2056309095 hasConceptScore W2056309095C2778257484 @default.
• W2056309095 hasConceptScore W2056309095C2778527774 @default.
• W2056309095 hasConceptScore W2056309095C2779567214 @default.
• W2056309095 hasConceptScore W2056309095C2781104129 @default.
• W2056309095 hasConceptScore W2056309095C2781411149 @default.
• W2056309095 hasConceptScore W2056309095C71924100 @default.
• W2056309095 hasIssue "4" @default.
• W2056309095 hasLocation W20563090951 @default.
• W2056309095 hasLocation W20563090952 @default.
• W2056309095 hasOpenAccess W2056309095 @default.
• W2056309095 hasPrimaryLocation W20563090951 @default.
• W2056309095 hasRelatedWork W2357477599 @default.
• W2056309095 hasRelatedWork W2365740287 @default.
• W2056309095 hasRelatedWork W2368847723 @default.
• W2056309095 hasRelatedWork W2374936819 @default.
• W2056309095 hasRelatedWork W2382659329 @default.
• W2056309095 hasRelatedWork W2384752226 @default.
• W2056309095 hasRelatedWork W2385433536 @default.
• W2056309095 hasRelatedWork W3028645424 @default.
• W2056309095 hasRelatedWork W3028646389 @default.
• W2056309095 hasRelatedWork W3030034575 @default.
• W2056309095 hasVolume "146" @default.
• W2056309095 isParatext "false" @default.
• W2056309095 isRetracted "false" @default.
• W2056309095 magId "2056309095" @default.
• W2056309095 workType "article" @default.